Daily Market Briefing

2026-08-25 · Money Checkup market briefing

# Biotech Surge and Commodities Rally Lead Mixed Market Higher

The stock market edged upward today, with the Nasdaq Composite leading the way at +0.66%, while the S&P 500 gained 0.32% and the Dow Jones added 0.30%. The Russell 2000 small-cap index was the lone laggard, slipping 0.26%—a subtle but telling split between larger-cap momentum and smaller names struggling for traction.

The day's most striking story wasn't the modest broad-market gains, but rather the dramatic rotation into biotech and natural resources. Biotech names dominated the gainers list, with Tenax Therapeutics soaring 25.4%, Capricor Therapeutics jumping 21.9%, and Pacific Biosciences climbing 18.8%, among others. This sector enthusiasm helped the broader market hold its footing even as traditionally defensive and industrial names stumbled. The commodities complex also shone brightly: packaged foods led all industries with a stunning equal-weight average return of +113.7% (22 companies including Mondelez, Archer-Daniels-Midland, and Kraft Heinz), while precious metals (+38.1%) and coal mining (+28.4%) also posted robust gains. Metal mining stocks added 24.2%, suggesting investors are betting on renewed demand or inflation concerns.

The weakness, however, was concentrated and meaningful. Engineering & construction stocks tumbled 17.8% on average—the worst-performing industry of the day—while blank-check SPACs fell 16.2%. Electronics distribution (led by GameStop's underperformance) declined 15.9%, and infrastructure-linked plays including water/sewer/power line construction dropped 11.8%. Among individual movers, Sadot Group cratered 29.4%, Alpha Modus Holdings fell 18.7%, and familiar consumer names like Bath & Body Works (−8.3%) and CVS Health (−13.2%) faced selling pressure. This pattern suggests a deliberate rotation out of capital-intensive, cyclical, and consumer-discretionary areas into growth and commodities.

On the corporate calendar, several companies filed their fiscal 2026 annual reports in the past few days. ScanSource (SCSC) showed a Health Score of 68.6, indicating relatively solid fundamental footing, while Coty (COTY) came in at 62.9. By contrast, Wolfspeed (WOLF) filed with a Health Score of just 35.1, and Prospect Capital (PSEC) registered 50.8—both suggest investors should dig deeper into what those filings reveal about operational trends. More concerning, five companies are currently flagged with going-concern audit notes, meaning auditors have substantial doubt about their ability to continue operating as ongoing businesses. Entrada Therapeutics (TRDA), FS KKR Capital (FSK), Bain Capital Specialty Finance (BCSF), New Mountain Finance (NMFC), and International Seaways (INSW) all carry this red flag—a signal that stakeholders should carefully review their latest disclosures.

Today's action reflects a bifurcated market: strong appetite for biotech speculation and commodity exposure, but clear stress in cyclical industrials and consumer sectors. The small-cap underperformance adds another layer of caution, as the Russell 2000 typically benefits most from synchronized economic growth. Money Checkup's screeners can help identify which of these sector leaders actually have durable value and quality metrics beneath the price spikes, and which of the decliners might represent genuine opportunities for patient investors.